跳转至内容
Merck
CN

F6937

FluoroShield

liquid, with 1,4-Diazabicyclo[2.2.2]octane

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
12171500
NACRES:
NA.47
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

Fluoroshield 与 1,4-二氮杂双环 [2.2.2] 辛烷, liquid

form

liquid

Quality Level

technique(s)

immunofluorescence: suitable

pH range

8.0-8.4

application(s)

diagnostic assay manufacturing
hematology
histology

storage temp.

2-8°C

General description

含 1,4-二氮杂双环 [2.2.2] 辛烷的 Fluoroshield 是一种水性封固剂,用于保存组织和细胞涂片的荧光。

Application

含1,4-二氮杂二环[2.2.2]辛烷的 Fluoroshield 可防止 FITC、Texas Red®、AMCA、ALEXA FLUOR 488、ALEXA FLUOR 594、Cy®染料和四甲基罗丹明的快速光漂白效应。

Biochem/physiol Actions

含 1,4-重氮杂环[2.2.2]辛烷封固剂的 Fluoroshield 使用 1,4-重氮杂环[2.2.2]辛烷(DABCO® 的通用版本)强化,这是一种抗褪色试剂,用于延缓荧光素和其他荧光染料的光漂白。

Legal Information

ALEXA FLUOR is a trademark of Life Technologies
Cy is a registered trademark of Cytiva
DABCO is a registered trademark of Air Products & Chemicals, Inc.
FluoroShield is a trademark of ImmunoBioScience Corp.
Texas Red is a registered trademark of Life Technologies


Still not finding the right product?


pictograms

Corrosion

signalword

Danger

hcodes

Hazard Classifications

Eye Dam. 1

存储类别

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Morphological changes of cortical and hippocampal neurons after treatment with VEGF and bevacizumab.
Latzer P, et al.
CNS Neuroscience & Therapeutics, 22(6), 440-450 (2016)
Anna Wolters et al.
Neural regeneration research, 16(11), 2243-2249 (2021-04-06)
One of the major challenges in emergency medicine is out-of-hospital cardiac arrest (OHCA). Every year, about 53-62/100 000 people worldwide suffer an out-of-hospital cardiac arrest with serious consequences, whereas persistent brain injury is a major cause of morbidity and mortality
Mariana L Casalia et al.
Annals of neurology, 82(4), 530-542 (2017-08-24)
A significant proportion of the more than 50 million people worldwide currently suffering with epilepsy are resistant to antiepileptic drugs (AEDs). As an alternative to AEDs, novel therapies based on cell transplantation offer an opportunity for long-lasting modification of epileptic



全球贸易项目编号

货号GTIN
F6937-20ML04061838105356